Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Jong Yup | - |
dc.contributor.author | Kim, Deukjoon | - |
dc.contributor.author | Kang, Suk Youn | - |
dc.contributor.author | Park, Woo-Kyu | - |
dc.contributor.author | Kim, Hyun Jung | - |
dc.contributor.author | Jung, Myung Eun | - |
dc.contributor.author | Son, Eun-Jung | - |
dc.contributor.author | Pae, Ae Nim | - |
dc.contributor.author | Kim, Jeongmin | - |
dc.contributor.author | Lee, Jinhwa | - |
dc.date.accessioned | 2024-01-20T18:04:38Z | - |
dc.date.available | 2024-01-20T18:04:38Z | - |
dc.date.created | 2021-09-04 | - |
dc.date.issued | 2010-11-15 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/130927 | - |
dc.description.abstract | Pyrimidine usually has good pharmacokinetic properties as a drug substance and considerable efforts have been devoted to develop pyrimidine derivatives into drug candidates. Arylpiperazine-containing pyrimidine 4-carboxamide derivatives were synthesized and evaluated for binding to serotonin receptors and transporter. Pyrimidine derivatives showed good antidepressant activity in FST (forced swimming test) animal model and also displayed no appreciable inhibitory activity against hERG channel blocking assay. Herein SAR studies of pyrimidine derivatives targeting serotonin receptors and transporter will be disclosed. (C) 2010 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.publisher | Pergamon Press Ltd. | - |
dc.subject | RECEPTOR ANTAGONIST | - |
dc.subject | REUPTAKE INHIBITORS | - |
dc.subject | BIPOLAR DISORDER | - |
dc.subject | NEUROPSYCHOLOGY | - |
dc.subject | NEFAZODONE | - |
dc.title | Arylpiperazine-containing pyrimidine 4-carboxamide derivatives targeting serotonin 5-HT2A, 5-HT2C, and the serotonin transporter as a potential antidepressant | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.bmcl.2010.09.081 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | Bioorganic & Medicinal Chemistry Letters, v.20, no.22, pp.6439 - 6442 | - |
dc.citation.title | Bioorganic & Medicinal Chemistry Letters | - |
dc.citation.volume | 20 | - |
dc.citation.number | 22 | - |
dc.citation.startPage | 6439 | - |
dc.citation.endPage | 6442 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000283052900019 | - |
dc.identifier.scopusid | 2-s2.0-77958061381 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | RECEPTOR ANTAGONIST | - |
dc.subject.keywordPlus | REUPTAKE INHIBITORS | - |
dc.subject.keywordPlus | BIPOLAR DISORDER | - |
dc.subject.keywordPlus | NEUROPSYCHOLOGY | - |
dc.subject.keywordPlus | NEFAZODONE | - |
dc.subject.keywordAuthor | Antidepressant | - |
dc.subject.keywordAuthor | Serotonin | - |
dc.subject.keywordAuthor | Piperazine | - |
dc.subject.keywordAuthor | Pyrimidine | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.